From Nasdaq: 2025-02-20 08:35:03

Endava PLC Sponsored ADR (DAVA) exceeded earnings expectations, reporting $0.38 per share compared to the estimated $0.32. Revenues were $250.63 million, beating estimates by 0.66%. The stock has underperformed the S&P 500 this year, leading to concerns about future performance and a Zacks Rank #4 (Sell) rating.

Stem, Inc. (STEM) is set to release its quarterly results on March 4, with an expected loss of $0.16 per share, down 71% in revenues. Analysts have revised EPS estimates 10.3% lower in the past 30 days. Investors are cautioned about the industry’s impact on stock performance and the Zacks Rank.

Investors are urged to consider the Zacks Rank and earnings outlook for Endava PLC Sponsored ADR (DAVA) before investing. Zacks Investment Research offers insights into the best stocks to buy for the next 30 days, with a history of outperforming the S&P 500 by over 24% annually since 1978.



Read more at Nasdaq: Endava PLC Sponsored ADR (DAVA) Beats Q2 Earnings and Revenue Estimates